Quadrant Capital Group LLC Xencor Inc Transaction History

Quadrant Capital Group LLC

$1.42 Billion
Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Xencor Inc stock. As of the latest transaction made, Quadrant Capital Group LLC holds 2,958 shares of XNCR stock, worth $69,513. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,958

Previous 5,964 50.4%

Holding current value

$69,513

Previous $112,000 47.32%

% of portfolio

0.0%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$15.7 - $21.65 $47,194 - $65,079	-3,006 Reduced 50.4%	2,958 $59,000
Q2 2024 Aug 12, 2024	SELL	$18.21 - $24.5 $5,717 - $7,693	-314 Reduced 5.0%	5,964 $112,000
Q1 2024 May 15, 2024	BUY	$18.65 - $26.52 $28,366 - $40,336	1,521 Added 31.97%	6,278 $138,000
Q4 2023 Feb 08, 2024	BUY	$16.53 - $21.42 $64,962 - $84,180	3,930 Added 475.21%	4,757 $100,000
Q3 2023 Nov 14, 2023	SELL	$20.08 - $25.39 $23,794 - $30,087	-1,185 Reduced 58.9%	827 $16,000
Q2 2023 Aug 09, 2023	SELL	$24.77 - $29.9 $41,142 - $49,663	-1,661 Reduced 45.22%	2,012 $50,000
Q1 2023 May 11, 2023	BUY	$25.95 - $36.95 $27,688 - $39,425	1,067 Added 40.94%	3,673 $102,000
Q4 2022 Feb 10, 2023	BUY	$24.79 - $30.86 $10,560 - $13,146	426 Added 19.54%	2,606 $67,000
Q3 2022 Nov 10, 2022	BUY	$24.62 - $32.44 $42,124 - $55,504	1,711 Added 364.82%	2,180 $57,000
Q2 2022 Aug 09, 2022	BUY	$19.74 - $29.01 $8,883 - $13,054	450 Added 2368.42%	469 $13,000
Q1 2022 May 06, 2022	SELL	$26.68 - $41.63 $693 - $1,082	-26 Reduced 57.78%	19 $1,000
Q4 2021 Feb 01, 2022	BUY	$33.67 - $43.44 $202 - $260	6 Added 15.38%	45 $2,000
Q3 2021 Nov 12, 2021	SELL	$30.65 - $35.68 $735 - $856	-24 Reduced 38.1%	39 $1,000
Q2 2021 Aug 09, 2021	BUY	$34.33 - $44.68 $823 - $1,072	24 Added 61.54%	63 $2,000
Q4 2020 Feb 16, 2021	BUY	$36.63 - $47.63 $549 - $714	15 Added 62.5%	39 $2,000
Q2 2020 Aug 13, 2020	BUY	$27.76 - $33.42 $666 - $802	24 New	24 $1,000

Others Institutions Holding XNCR

# of Institutions

216

Shares Held

71.7M

Call Options Held

2.5K

Put Options Held

7.9K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.4B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Xencor Inc Transaction History